Atom Investors’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-76,487
Closed -$8.12M 710
2025
Q4
$8.12M Buy
76,487
+40,080
+110% +$4.65M 0.64% 28
2025
Q3
$4.62M Buy
+36,407
New +$4.33M 0.35% 82
2024
Q4
Sell
-40,829
Closed -$3.95M 528
2024
Q3
$3.95M Buy
40,829
+33,544
+460% +$3.01M 0.41% 72
2024
Q2
$625K Sell
7,285
-44,107
-86% -$3.7M 0.06% 309
2024
Q1
$4.24M Buy
51,392
+23,946
+87% +$1.75M 0.53% 50
2023
Q4
$1.83M Buy
27,446
+579
+2% +$37.5K 0.32% 103
2023
Q3
$1.8M Buy
26,867
+6,012
+29% +$414K 0.41% 60
2023
Q2
$1.41M Sell
20,855
-953
-4% -$59.7K 0.54% 37
2023
Q1
$1.18M Sell
21,808
-743
-3% -$43.2K 0.64% 34
2022
Q4
$1.35M Buy
+22,551
New +$1.23M 0.67% 38
2022
Q3
Sell
-53,177
Closed -$2.37M 318
2022
Q2
$2.37M Buy
+53,177
New +$2.73M 1.04% 16
2022
Q1
Sell
-7,888
Closed -$410K 236
2021
Q4
$410K Sell
7,888
-11,838
-60% -$611K 0.07% 183
2021
Q3
$1.18M Sell
19,726
-14,275
-42% -$898K 0.1% 117
2021
Q2
$2.11M Buy
34,001
+30,456
+859% +$2.03M 0.27% 72
2021
Q1
$231K Buy
+3,545
New +$231K 0.04% 209
2019
Q1
Sell
-5,600
Closed -$275K 559
2018
Q4
$275K Buy
+5,600
New +$319K 0.03% 486

Other funds holding EHC

Atom Investors's EHC Position: Q1 2026 in Review

Atom Investors sold out of Encompass Health (EHC) in Q1 2026, closing a stake of 76,487 shares — an estimated $8.12M sold.

Atom Investors first reported a position in EHC in Q4 2018 and held it in 16 quarters. The position peaked at $8.12M in Q4 2025. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Atom Investors reported no remaining Encompass Health position as of Q1 2026 after selling out during the quarter.
  • Atom Investors sold 76,487 Encompass Health shares in Q1 2026, an estimated $8.12M.
  • Atom Investors first reported a position in Encompass Health in Q4 2018 and held it in 16 quarters.
  • Atom Investors's Encompass Health position peaked at $8.12M in Q4 2025.
  • 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Atom Investors's 13F filing for Q1 2026, filed 15 May 2026.